Experts say that semaglutide and tirzepatide can help patients with heart failure lose weight, but limited NHS access is ...

For patients with obesity initiating pharmacotherapy with semaglutide or tirzepatide, weight loss at one year is 8.7 percent ...

Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...

Deep Apple is the latest biotech to be tapped by Novo Nordisk as the drugmaker aims to regain market share lost to Eli Lilly.

Detailed price information for Lexaria Bioscience Corp (LEXX-Q) from The Globe and Mail including charting and trades.

With three months since its launch in India, according to latest Pharmatrac data, Mounjaro clocked Rs 12.6 crore in sales in ...

New UK research reveals that combining weight loss injections with coaching and regular tracking can lead to 53% more ...

How weight loss demand is draining Europe’s diabetes drug supply, as countries adopt varying speeds of approach to medicinal ...

It is important to note that Ozempic and blindness are not usually connected, and vision loss is not a commonly reported or ...

How weight loss demand is draining Europe’s diabetes drug supply, as countries adopt varying speeds of approach to medicinal ...

Ozempic teeth is the latest concern associated with the ‘miracle’ weight loss drug Ozempic Read to know more about this side ...

"We recommend that any patients experiencing side effects while taking GLP-1 receptor agonists including Wegovy® (semaglutide ...